See what members are saying about chronic hives treatments, the side effects to expect, and the drug basics.
All treatment information is medically reviewed · December 10, 2025
Overview
Rhapsido is approved by the U.S. Food and Drug Administration (FDA) for the treatment of chronic spontaneous urticaria (CSU), a type of hives, in adults who continue to experience symptoms despite taking H1…
Overview
Xolair is approved by the U.S. Food and Drug Administration (FDA) for the treatment of chronic spontaneous urticaria (CSU) in adults and adolescents aged 12 years and older who continue to have hives despite…
Become a member to get even more